Found 15 hits for monomerid = 3201 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Protein kinase C alpha type
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
PKC alpha and beta-2
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C beta I |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
PKC alpha and beta-2
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
Protein kinase C, gamma
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
Protein kinase C delta type
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
Protein kinase C, epsilon
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
Protein kinase C, eta
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
cAMP-Dependent Protein Kinase (PKA)
(Bos taurus (bovine)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB
UniProtKB/SwissProt
GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description The activity of PKA, activated by cAMP, is measured by its ability to transfer phosphate from [gamma-32P]ATP to histone. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
Protein kinase C alpha type
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C alpha |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
Protein kinase C, eta
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C eta |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
Protein kinase C, gamma
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C gamma |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
Protein kinase C delta type
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C delta |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
Protein kinase C, epsilon
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C epsilon |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
PKC alpha and beta-2
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C beta I |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
PKC alpha and beta-2
(Homo sapiens (Human)) | BDBM3201
((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H23NO9/c28-16-6-4-13(5-7-16)8-15-11-27-12-21(15)36-26(35)14-9-19(30)23(20(31)10-14)24(32)22-17(25(33)34)2-1-3-18(22)29/h1-7,9-10,15,21,27-31H,8,11-12H2,(H,33,34)/t15-,21-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |